v3.26.1
Unaudited Statement of Changes in Shareholders’ Deficit - 3 months ended Mar. 31, 2026 - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional paid-in capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 863 $ 24,137 $ (60,111) $ (35,111)
Balance (in Shares) at Dec. 31, 2025 8,625,000      
Sale of 395,000 Private Placement Class A Shares $ 40 3,949,960 3,950,000
Sale of 395,000 Private Placement Class A Shares (in Shares) 395,000      
Fair value of Rights at issuance 8,625,000 8,625,000
Allocated value of transaction costs to Private Placement Shares 181,299 181,299
Allocated value of transaction costs to Rights (395,875) (395,875)
Full exercise of over-allotment option 400,500 400,500
Accretion for Class A ordinary shares to redemption amount (12,021,923) (12,685,963) (24,707,886)
Net income 1,124,785 1,124,785
Balance at Mar. 31, 2026 $ 40 $ 863 $ (11,220,789) $ (11,219,886)
Balance (in Shares) at Mar. 31, 2026 395,000 8,625,000